Invasive group A, C and G streptococcal disease in western Norway: Virulence gene profiles, clinical features and outcomes

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 358-364

  Kittang, B R ^a,b   Bruun, T ^b   Langeland, N ^a   Mylvaganam, H ^b   Glambek, M ^a   Skrede, S ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Emm gene; GAS; GCS; GGS; Invasive infections; Streptococcal phospholipase A2 gene; Superantigen genes

Indexed keywords

PHOSPHOLIPASE A2; SUPERANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; FATALITY; FEMALE; HUMAN; INCIDENCE; INVASIVE GROUP A STREPTOCOCCAL DISEASE; INVASIVE GROUP C STREPTOCOCCAL DISEASE; INVASIVE GROUP G STREPTOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; NECROTIZING FASCIITIS; NORWAY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS INFECTION;

EID: 79751482609     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03253.x     Document Type: Article

References (32)

1. Beres SB, Sylva GL, Barbian KD et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA 2002; 99: 10078-10083.
2. Luca-Harari B, Darenberg J, Neal S et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2009; 47: 1155-1165.
3. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005; 11: 569-576.
4. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect 2009; 15: 286-288.
5. Broyles LN, van Beneden C, Beall B et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009; 48: 706-712.
6. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Ubukata K. Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect 2009. [Epub ahead of print].
7. Sitkiewicz I, Nagiec MJ, Sumby P, Butler SD, Cywes-Bentley C, Musser JM. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci USA 2006; 103: 16009-16014.
8. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29: 1562-1567.
9. Igwe EI, Shewmaker PL, Facklam RR, Farley MM, van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett 2003; 229: 259-264.
10. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 2008; 46: 79-86.
11. Ikebe T, Murayama S, Saitoh K et al. Surveillance of severe invasive group-G streptococcal infections and molecular typing of the isolates in Japan. Epidemiol Infect 2004; 132: 145-149.
12. Davies MR, McMillan DJ, Beiko RG et al. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 2007; 44: 1442-1454.
13. Hashikawa S, Iinuma Y, Furushita M et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004; 42: 186-192.
14. Meisal R, Hoiby EA, Aaberge IS, Caugant DA. Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003. J Clin Microbiol 2008; 46: 2102-2105.
15. Meisal R, Andreasson IK, Hoiby EA, Aaberge IS, Michaelsen TE, Caugant DA. Streptococcus pyogenes isolates causing severe infections in Norway, 2006-2007: emm types, multilocus sequence types and superantigen profiles. J Clin Microbiol 2010; 48: 842-851.
16. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33: 1538-1548.
17. Breiman RF, Davis JP, Facklam RR et al. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269: 390-391.
18. Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
19. Kittang BR, Langeland N, Mylvaganam H. Distribution of emm types and subtypes among noninvasive group A, C and G streptococcal isolates in western Norway. APMIS 2008; 116: 457-464.
20. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63: 994-1003.
21. Lintges M, Arlt S, Uciechowski P et al. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity. Int J Med Microbiol 2007; 297: 471-478.
22. Darenberg J, Luca-Harari B, Jasir A et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45: 450-458.
23. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32: 1535-1541.
24. O'Loughlin RE, Roberson A, Cieslak PR et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45: 853-862.
25. Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 2005; 43: 1678-1683.
26. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344: 1111-1115.
27. Mylvaganam H, Bruun T, Vindenes HA, Langeland N, Skrede S. Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway. Clin Microbiol Infect 2009; 15: 245-252.
28. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 2001; 69: 2416-2427.
29. Ahmad Y, Gertz RE Jr, Li Z et al. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol 2009; 47: 2046-2054.
30. Schmitz FJ, Beyer A, Charpentier E et al. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 2003; 188: 1578-1586.
31. Nagiec MJ, Lei B, Parker SK et al. Analysis of a novel prophage-encoded group A Streptococcus extracellular phospholipase A(2). J Biol Chem 2004; 279: 45909-45918.
32. Brandt CM, Schweizer KG, Holland R, Lutticken R, Freyaldenhoven BS. Lack of mitogenic activity of speG- and speGdys-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections. Int J Med Microbiol 2005; 295: 539-546.